How to buy Chiasma stock | 4.03

Chiasma, Inc is a biotechnology business based in the US. Chiasma shares (CHMA) are listed on the NASDAQ and all prices are listed in US Dollars. Chiasma employs 68 staff and has a market cap (total outstanding shares value) of USD$231.2 million.

How to buy shares in Chiasma

1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
3. Search for Chiasma. Find the stock by name or ticker symbol: CHMA. Research its history to confirm it's a solid investment against your financial goals.
4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Chiasma reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
5. Decide on how many to buy. At last close price of USD$4.03, weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Chiasma, depending on your broker.
6. Check in on your investment. Congratulations, you own a part of Chiasma. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

How has coronavirus impacted Chiasma's share price?

Since the stock market crash in March caused by coronavirus, Chiasma's share price has had significant negative movement.

Its last market close was USD$4.03, which is 12.39% down on its pre-crash value of USD$4.6 and 39.93% up on the lowest point reached during the March crash when the shares fell as low as USD$2.88.

If you had bought USD$1,000 worth of Chiasma shares at the start of February 2020, those shares would have been worth USD$723.93 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth USD$824.14.

Chiasma share price

Use our graph to track the performance of CHMA stocks over time.

Chiasma shares at a glance

• Key figures

Information last updated 2020-10-20.

Latest market close	USD$4.03
52-week range	USD$2.88 - USD$7.75
50-day moving average	USD$4.6811
200-day moving average	USD$5.0648
Wall St. target price	USD$13.6
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	USD$-1.227

Buy Chiasma shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

Is it a good time to buy Chiasma stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of Chiasma, Inc by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Chiasma price performance over time

Historical closes compared with the close of $4.03 from 2020-11-16

1 week (2020-11-23)	2.54%
1 month (2020-10-30)	7.47%
3 months (2020-08-28)	-19.88%
6 months (2020-05-29)	-35.52%

1 year (2019-11-29)	-24.67%
2 years (2018-11-30)	0.25%
3 years (2017-11-30)	123.89%
5 years (2015-11-30)	-81.84%

Chiasma financials

Gross profit TTM	USD$0
Return on assets TTM	-45.71%
Return on equity TTM	-109.1%
Profit margin	0%
Book value	$1.23
Market capitalisation	USD$231.2 million

TTM: trailing 12 months

Shorting Chiasma shares

There are currently 1.8 million Chiasma shares held short by investors – that's known as Chiasma's "short interest". This figure is 9.8% up from 1.7 million last month.

There are a few different ways that this level of interest in shorting Chiasma shares can be evaluated.

Chiasma's "short interest ratio" (SIR)

Chiasma's "short interest ratio" (SIR) is the quantity of Chiasma shares currently shorted divided by the average quantity of Chiasma shares traded daily (recently around 508628.29131653). Chiasma's SIR currently stands at 3.57. In other words for every 100,000 Chiasma shares traded daily on the market, roughly 3570 shares are currently held short.

However Chiasma's short interest can also be evaluated against the total number of Chiasma shares, or, against the total number of tradable Chiasma shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Chiasma's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 Chiasma shares in existence, roughly 30 shares are currently held short) or 0.035% of the tradable shares (for every 100,000 tradable Chiasma shares, roughly 35 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Chiasma.

Find out more about how you can short Chiasma stock.

Chiasma share dividends

We're not expecting Chiasma to pay a dividend over the next 12 months.

Chiasma share price volatility

Over the last 12 months, Chiasma's shares have ranged in value from as little as $2.88 up to $7.75. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Chiasma's is 1.615. This would suggest that Chiasma's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Chiasma overview

Chiasma, Inc., a clinical late-stage biopharmaceutical company, focuses on developing oral medications using transient permeability enhancer technology platform for the treatment of rare and serious chronic disease worldwide. The company develops oral octreotide capsules for adult patients under the MYCAPSSA name, which is in Phase III clinical trials for the treatment of acromegaly, a condition that results in the body's production of excess growth hormone. Chiasma, Inc. was founded in 2001 and is headquartered in Needham, Massachusetts.

Frequently asked questions

• What percentage of Chiasma is owned by insiders or institutions?

  Currently 4.517% of Chiasma shares are held by insiders and 82.544% by institutions.

• How many people work for Chiasma?

  Latest data suggests 68 work at Chiasma.

• When does the fiscal year end for Chiasma?

  Chiasma's fiscal year ends in December.

• Where is Chiasma based?

  Chiasma's address is: Building C East, Needham, MA, United States, 02494

• What is Chiasma's ISIN number?

  Chiasma's international securities identification number is: US16706W1027

• What is Chiasma's CUSIP number?

  Chiasma's Committee on Uniform Securities Identification Procedures number is: 16706W102